www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Sigma_aldrich Logo
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Mirabegron
english deutsch español

Suppliers for

Mirabegron

Properties

CAS   223673-61-8 
Formula   C21H24N4O2S 

Structure

25 Registered suppliers

rd Simagchem Corporation P.R.China
rd Sancai Industry Co.,Ltd. P.R.China
rd Hangzhou Keying Chem Co., Ltd. P.R.China
rd H&Z Industry Co.,Ltd P.R.China
rd Xingrui Industry Co., Limited P.R.China
rd Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
rd Capot Chemical Co., Ltd. P.R.China CD details
rd Leap Chem Co., Ltd P.R.China CD details
rd Chemvon Biotechnology Co. Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Guangzhou Topwork Chemical Co., Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Hangzhou Verychem Science & Technology Co., Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Arakato Development Ltd Hong Kong
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd FUDAW INDUSTRY LTD P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Shandong Ench Chemical Co.,Ltd P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Shandong Minglang Chemical Co., Ltd P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Hangzhou Zhongqi Chem Co., Ltd P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Nantong Xindao Biotech Ltd P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506

rd Finetech Industry Limited P.R.China CD details
rd BOC Sciences USA CD details
rd Shandong SanYoung Industry Co., Ltd P.R.China
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
rd AK Scientific, Inc. USA
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
rd Chemos GmbH & Co. KG Germany
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
rd World. Chem. Co., Ltd. P.R.China
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
rd CM Fine Chemicals Switzerland
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
rd Santa Cruz Biotechnology, Inc. USA
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178

More details are to be found here
Detailed information on the suppliers of Mirabegron

Properties:

... more properties and specification on Mirabegron
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved